Mesothelioma symptoms like a cough and shortness of breath can resemble bronchitis, but these diseases have different causes ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

25, 2024 — A new method of scanning lungs is able to show in real time how air moves in and out of the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary ...

University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to ...

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

The Bronchiectasis and NTM Association has accepted UC San Francisco (UCSF) into its Bronchiectasis and NTM Care Center Network (CCN), recognizing UCSF’s dedication to providing high-quality medical ...

17 Since pulmonary toxicity resulting from high oxygen ... in the viscosity and type of secretion are all consequences of therapy. The loss of ciliary mucosa, at first by necrosis and later ...

To that end, GOLD guidelines for COPD recommend tailoring treatment based on risk of exacerbation and symptom severity as well as on patient preference, including cost, availability, and the user’s ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...